Takip et
Perran Fulden Yumuk
Perran Fulden Yumuk
Koç Üniversitesi Tıp Fakültesi
ku.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label …
The Lancet 393 (10183), 1819-1830, 2019
33102019
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
M Martin, FA Holmes, B Ejlertsen, S Delaloge, B Moy, H Iwata, ...
The lancet oncology 18 (12), 1688-1700, 2017
7012017
Pembrolizumab plus ipilimumab or placebo for metastatic non–small-cell lung cancer with PD-L1 tumor proportion score≥ 50%: Randomized, double-blind phase III KEYNOTE-598 study
M Boyer, MAN Şendur, D Rodríguez-Abreu, K Park, DH Lee, I Çiçin, ...
Journal of Clinical Oncology, JCO. 20.03579, 2021
2152021
HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples.
M Gumus, PF Yumuk, T Salepci, M Aliustaoglu, F Dane, M Ekenel, ...
Journal of experimental & clinical cancer research: CR 25 (4), 515-521, 2006
1392006
Extrapulmonary small cell carcinoma: multimodality treatment results
M Sengoz, U Abacioglu, T Salepci, F Eren, F Yumuk, S Turhal
Tumori Journal 89 (3), 274-277, 2003
972003
Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy
HF Batirel, M Metintas, HB Caglar, G Ak, PF Yumuk, B Yildizeli, M Yuksel
The Journal of thoracic and cardiovascular surgery 151 (2), 478-484, 2016
752016
Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic …
D Cabuk, G Basaran, C Celikel, F Dane, PF Yumuk, MS Iyikesici, ...
Oncology 72 (1-2), 111-117, 2007
732007
Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer
U KEFELI, F Dane, PF Yumuk, A Karamanoglu, S Iyikesici, G Basaran, ...
European Journal of Cancer Care 18 (2), 191-194, 2009
702009
Modified Glasgow prognostic score, prognostic nutritional index and ECOG performance score predicts survival better than sarcopenia, cachexia and some inflammatory indices in …
B Demirelli, NA Babacan, Ö Ercelep, MA Öztürk, S Kaya, E Tanrıkulu, ...
Nutrition and cancer 73 (2), 230-238, 2021
592021
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study …
J Gligorov, B Ataseven, M Verrill, M De Laurentiis, KH Jung, HA Azim, ...
European Journal of Cancer 82, 237-246, 2017
582017
Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients
RM Umar, S Apikoglu-Rabus, PF Yumuk
International Journal of Clinical Pharmacy 42 (2), 652-661, 2020
462020
Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey
G Basaran, NS Turhal, D Cabuk, N Yurt, G Yurtseven, M Gumus, ...
Medical oncology 28, 409-415, 2011
402011
Epithelioid hemangioendothelioma with multiple organ involvement: report of two cases and review of the literature
C Celikel, PF Yumuk, G Basaran, B Yildizeli, N Kodalli, R Ahiskali
Apmis 115 (7), 881-888, 2007
382007
Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma
U Abacioglu, HB Caglar, PF Yumuk, Z Akgun, BM Atasoy, M Sengoz
Journal of neuro-oncology 103, 585-593, 2011
332011
What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery?
M Gumus, PF Yumuk, G Atalay, M Aliustaoglu, B Macunluoglu, F Dane, ...
Tumori Journal 91 (2), 168-172, 2005
332005
The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients
PF Yumuk, SZ Aydin, F Dane, M Gumus, M Ekenel, M Aliustaoglu, ...
International journal of colorectal disease 19, 609-610, 2004
322004
Chordoma: a case series and review of the literature
O Alan, T Akin Telli, O Ercelep, E Tanrikulu Simsek, T Basoglu Tuylu, ...
Journal of Medical Case Reports 12, 1-5, 2018
312018
GLASS: Global Lorlatinib for ALK (+) and ROS1 (+) retrospective Study: real world data of 123 NSCLC patients
N Peled, R Gillis, S Kilickap, P Froesch, S Orlov, E Filippova, U Demirci, ...
Lung Cancer 148, 48-54, 2020
302020
Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer
T Korkmaz, S Seber, K Okutur, G Basaran, F Yumuk, F Dane, T Ones, ...
Biomarkers 18 (1), 88-94, 2013
292013
Port Needles: Do They Need to be Removed as Frequently in Infusional Chemotherapy?
A Karamanoglu, FP Yumuk, M Gumus, M Ekenel, M Aliustaoglu, ...
Journal of Infusion Nursing 26 (4), 239-242, 2003
292003
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20